Imanova has world-leading expertise in imaging sciences and their application to the understanding of disease and translational drug development. Having started as an innovative joint venture between UK's Medical Research Council the Imperial College London, King’s College London and University College London, Imanova has been acquired by Invicro in August 2017. Imanova is a company with a depth of understanding in drug development and extensive experience using imaging to facilitate the development pipeline. Our academic expertise and extensive links with clinicians and scientists in our shareholder institutions provide unrivalled capabilities to facilitate drug development.

Speak to our team of
experts to understand
more about how imaging
helps you achieve your
objectives in early stage
drug development.

Contact Imanova today